Pancreatic Cancer Research

ResearcherPfizer (United States)Active in the last 2 years

Edward Wang

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5006501240. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

  1. The close association of Muribaculum and PA (10:0/a-17:0) with the occurrence of pancreatic ductal adenocarcinoma and immunotherapy. Co-author DOI 10.3389/fimmu.2024.1505966↗
  2. A phase I dose escalation trial of tremelimumab (CP-675,206) in combination with gemcitabine in chemotherapy-naive patients with metastatic pancreatic cancer. Co-author DOI 10.1093/annonc/mdu205↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kuiwu Ren · 1 shared paper, 2024 · strength 0.20
  2. Chunlong Liu · 1 shared paper, 2024 · strength 0.20
  3. Panpan Wu · 1 shared paper, 2024 · strength 0.20
  4. Jiangtao Yu · 1 shared paper, 2024 · strength 0.20
  5. Kun Song · 1 shared paper, 2024 · strength 0.20
  6. Francesco Leone · 1 shared paper, 2014 · strength 0.04
  7. Massimo Aglietta · 1 shared paper, 2014 · strength 0.04
  8. Carlo Antonio Barone · 1 shared paper, 2014 · strength 0.04
  9. Michael B. Sawyer · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.